iVascular has announced that its Angiolite drug-eluting stent (DES) is available 44mm and 49mm lengths, for the treatment of long lesions. The longer stent sizes received the CE mark approval for the treatment of diffuse lesions.
Angiolite is a sirolimus-eluting coronary stent, indicated for patients with symptomatic ischaemic heart disease due to de novo stenotic and restenotic lesions and patients with occlusive disease due to acute myocardial infarction.
The device is composed of alternating links to achieve a homogeneous arterial coverage with high rates of endothelialisation due to its fluorinated polymer and TransferWise, proprietary iVascular nanotechnology.
In a press release, iVascular said that the new lengths will facilitate the treatment of long lesions in the coronary arteries. This can help to reduce cost and increase procedural efficiency, avoiding complications such as stents overlapping, and less intervention time versus the use of more than one DES, the company said. The 44mm and 49mm lengths are available for 2.50, 2.75, 3.0, 3.5, 4.0 diameter stents.